GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » EV-to-EBITDA

No.25 Central Pharmaceutical JSC (HSTC:UPH) EV-to-EBITDA : (As of Jun. 01, 2025)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, No.25 Central Pharmaceutical JSC's enterprise value is ₫0.00 Mil. No.25 Central Pharmaceutical JSC does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate No.25 Central Pharmaceutical JSC's EV-to-EBITDA at this moment.

The historical rank and industry rank for No.25 Central Pharmaceutical JSC's EV-to-EBITDA or its related term are showing as below:

HSTC:UPH's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.08
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-01), No.25 Central Pharmaceutical JSC's stock price is ₫9500.00. No.25 Central Pharmaceutical JSC does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate No.25 Central Pharmaceutical JSC's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

No.25 Central Pharmaceutical JSC EV-to-EBITDA Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC EV-to-EBITDA Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
EV-to-EBITDA

No.25 Central Pharmaceutical JSC Semi-Annual Data
EV-to-EBITDA

Competitive Comparison of No.25 Central Pharmaceutical JSC's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, No.25 Central Pharmaceutical JSC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

No.25 Central Pharmaceutical JSC's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, No.25 Central Pharmaceutical JSC's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where No.25 Central Pharmaceutical JSC's EV-to-EBITDA falls into.


;
;

No.25 Central Pharmaceutical JSC EV-to-EBITDA Calculation

No.25 Central Pharmaceutical JSC's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=

No.25 Central Pharmaceutical JSC  (HSTC:UPH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

No.25 Central Pharmaceutical JSC's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9500.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

No.25 Central Pharmaceutical JSC EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

No.25 Central Pharmaceutical JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » EV-to-EBITDA
Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
Website
https://uphace.vn
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines